Mevastatin suppresses melanogenesis by lowering the levels of cyclic adenosine monophosphate and cholesterol
- 13 July 2016
- journal article
- Published by Wiley in Experimental Dermatology
- Vol. 25 (10) , 820-822
Abstract
No abstract availableKeywords
Funding Information
- Korean Health Technology R&D Project
- Ministry of Health & Welfare, Republic of Korea (HNC13C0076)
This publication has 9 references indexed in Scilit:
- Fluvastatin Influences Hair Color in C57Bl/6 MiceInternational Journal of Molecular Sciences, 2013
- Artemisinic acid inhibits melanogenesis through downregulation of C/EBP α-dependent expression of HMG-CoA reductase geneFood and Chemical Toxicology, 2013
- Fluvastatin increases tyrosinase synthesis induced by α-melanocyte-stimulating hormone in B16F10 melanoma cellsPharmacological Reports, 2010
- Cholesterol regulates melanogenesis in human epidermal melanocytes and melanoma cellsExperimental Dermatology, 2009
- Inhibitory effect of novel diallyldisulfide analogs on HMG-CoA reductase expression in hypercholesterolemic rats: CREB as a potential upstream targetLife Sciences, 2009
- Physiological factors that regulate skin pigmentationBioFactors, 2009
- Methyl-β-cyclodextrin, a specific cholesterol-binding agent, inhibits melanogenesis in human melanocytes through activation of ERKArchives of Dermatological Research, 2008
- Cyclic AMP a Key Messenger in the Regulation of Skin PigmentationPigment Cell Research, 2000
- Competitive inhibition of 3‐hydroxy‐3‐methylglutaryl coenzyme a reductase by ML‐236A and ML‐236B fungal metabolites, having hypocholesterolemic activityFEBS Letters, 1976